Zofran
US$ 21.52
glp-1 agonists thyroid cancer Overscreening of patients on glucagon-like peptide-1 receptor agonists: A second “epidemic” of overdiagnosis? I'm often asked about GLP-1
Description
Ishibashi, Y
Releases WADA publishes 2025 Prohibited List Today, the World Anti-Doping Agency (WADA) publishes the 2025 List of Prohibited Substances and Methods (List), which was approved by WADAs Executive Committee (ExCo) during its meeting on 12 September 2024 and enters into force on 1 January 2025
Ismaeil A, Babiker F, Al-Sabah S
Cardiac GLP-1R signaling pathways There is considerable overlap between pathways induced by the GLP-1R activation
Immune-modulating peptides may influence angiogenesis, fibrosis, or tumor biology, requiring indication-specific risk assessment
